NCT01378988View on ClinicalTrials.gov

Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2011

Conditions
SedationPain
Interventions
DRUG

Dexmedetomidine

For sedation according to protocol

Trial Locations (1)

15224

Children's Hospital of Pittusburgh of UPMC, Pittsburgh

All Listed Sponsors
lead

Hospira, now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT01378988 - Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through <24 Months | Biotech Hunter | Biotech Hunter